Company Profile



New York, NY, USA

Founded Year




Operating Status


Social Media


Thomas Clozel
Co-Founder, CEO

Gilles Wainrib
Co-Founder, CSO


In the ever-evolving landscape of healthcare research, Owkin has emerged as a pioneering force, combining the power of artificial intelligence (AI) and blockchain technology to revolutionize the way medical discoveries are made.

Founded in 2016, Owkin has swiftly established itself as a leading innovator in the field, garnering attention for its groundbreaking approach to collaborative intelligence and its commitment to reshaping the future of healthcare.

Leveraging AI and machine learning algorithms, Owkin has developed a sophisticated platform that enables researchers and healthcare professionals to extract valuable insights from vast amounts of medical data.

By analyzing diverse datasets, encompassing clinical, genomic, and imaging information, Owkin's platform can uncover patterns and associations that were previously hidden, providing crucial guidance for researchers in their quest to develop new treatments and improve patient outcomes.

One of the core strengths of Owkin's platform lies in its ability to facilitate secure and privacy-preserving collaborations. Utilizing blockchain technology, Owkin ensures that sensitive patient data remains protected, while still enabling researchers to tap into the collective intelligence of a global network of medical experts.

This unique approach allows for the seamless exchange of knowledge and expertise, transcending geographical boundaries and accelerating the pace of medical advancements.
Owkin has gained recognition for its groundbreaking achievements in various domains of healthcare research.

In the field of oncology, for instance, the company has successfully applied its AI algorithms to predict patient response to immunotherapy, a breakthrough that holds tremendous potential for personalized cancer treatments. Furthermore, Owkin has partnered with prominent academic institutions and pharmaceutical companies, forging alliances that enhance the accessibility of valuable datasets and foster collaborative research efforts.

Driven by a team of seasoned experts in AI, machine learning, and biomedical research, Owkin continues to push the boundaries of what is possible in healthcare innovation. The company's commitment to ethical and responsible use of AI is evident in its emphasis on transparency, explainability, and reproducibility of results.

By bridging the gap between data science and medical expertise, Owkin is transforming the way healthcare research is conducted, leading to more precise diagnoses, targeted therapies, and ultimately, improved patient care.

As the healthcare industry embraces the era of digital transformation, Owkin stands at the forefront, reshaping the landscape with its visionary approach. By harnessing the power of AI and blockchain technology, Owkin empowers researchers and clinicians to make groundbreaking discoveries that have the potential to save countless lives.


Owkin uses AI to find the right treatment for every patient

We bridge shared innovation challenges between biopharma and academic researchers and close the translational gap between complex biology and new drugs.

Similar Companies

About Us

futureTEKnow is a global database of emerging technology companies. Discover the latest disruptors and innovators in the field.



Trending Today